Compare BMA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMA | HAE |
|---|---|---|
| Founded | 1966 | 1971 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2006 | 1996 |
| Metric | BMA | HAE |
|---|---|---|
| Price | $75.21 | $108.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $99.33 | $84.13 |
| AVG Volume (30 Days) | 236.4K | ★ 502.5K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $16.25 | N/A |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ $33.22 | $150.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.30 | $47.32 |
| 52 Week High | $106.15 | $110.45 |
| Indicator | BMA | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 71.95 |
| Support Level | $67.99 | $100.53 |
| Resistance Level | $79.54 | $109.57 |
| Average True Range (ATR) | 2.54 | 2.65 |
| MACD | 0.13 | -0.23 |
| Stochastic Oscillator | 21.01 | 86.39 |
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. The company generates the majority of its revenue from Argentina.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.